Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | MDNA55 |
Synonyms | |
Therapy Description |
MDNA55 (PRX-321) is a fusion protein that includes IL-4 fused to a truncated form of Pseudomonas exotoxin, which once internalized by tumor cells expressing IL-4 receptors may lead to apoptosis (NCI Drug Dictionary). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
MDNA55 | PRX-321|PRX321 | MDNA55 (PRX-321) is a fusion protein that includes IL-4 fused to a truncated form of Pseudomonas exotoxin, which once internalized by tumor cells expressing IL-4 receptors may lead to apoptosis (NCI Drug Dictionary). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT02858895 | Phase II | MDNA55 | Convection-Enhanced Delivery (CED) of MDNA55 in Adults With Recurrent or Progressive Glioblastoma | Completed | USA | 0 |